Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 20,24120,252 of 20,252 grants

Completed TRAINING, INDIVIDUAL
Studies of the structural and functional basis of neuroblastoma drug resistance
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT Neuroblastoma is the most common extracranial tumor of young children, and the five-year overall survival of children with high-risk disease is less than 5...

$517.5K
USD
Completed TRAINING, INDIVIDUAL
Elucidating Oncogenic Mechanisms Underlying Wilms Tumor Using Kidney Organoids
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT Wilms tumor is the most common pediatric kidney cancer. Blastemal-predominant tumors are classified as high-risk and have demonstrated resistance to chemot...

$382.6K
USD
Completed TRAINING, INDIVIDUAL
Impact of the microbiome on chemotherapeutic outcomes
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT Cytotoxic chemotherapeutic agents are a key component of cancer therapy, but they have unpredictable treatment responses and considerable treatment-related...

$421.4K
USD
Completed TRAINING, INDIVIDUAL
Brachytherapy to achieve in situ cancer vaccination
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2023

Project Summary/Abstract We aim to improve the cure rates for metastatic cancers. To achieve this we propose a combined modality approach to stimulate and diversify an endogenous a...

$415.4K
USD
Completed TRAINING, INDIVIDUAL
Role of SerpinB3 in glioblastoma cancer stem cells
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2022

Project Summary ROLE OF SERPINB3 IN GLIOBLASTOMA CANCER STEM CELLS Glioblastoma (GBM) is the most aggressive primary malignant brain tumor, with a median survival of 18-20 months....

$205.5K
USD
Completed TRAINING, INDIVIDUAL
Population-Targeted Risk Prediction to Guide Breast Cancer Screening in Cameroon
NATIONAL CANCER INSTITUTE University of California Berkeley United States 2021 – 2022

Project Summary/Abstract: As cancer becomes an increasingly important cause of mortality in sub-Saharan Africa, nations must improve their capacity to diagnose and treat the malign...

$677.5K
USD
Completed TRAINING, INDIVIDUAL
Characterizing the effects of cis-regulatory variation on patient outcomes and treatment response in Multiple Myeloma
NATIONAL CANCER INSTITUTE Translational Genomics Research Inst United States 2021 – 2023

ABSTRACT Multiple Myeloma (MM) is a malignancy of plasma cells and the second most common hematological cancer accounting for 2% of cancer deaths. MM is associated with a poor prog...

$785.5K
USD
Completed NON-SBIR/STTR RPGS
Genetic analysis of lung cancer susceptibility
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2022

Abstract Although tobacco exposure is the major determinant of lung cancer, only about 15% of smokers develop lung cancer. In this study, we seek to identify genetic effects that i...

$800K
USD
Completed TRAINING, INDIVIDUAL
Determining the Mechanism of Transformation for Rhabdomyosarcoma
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital Gr... United States 2021 – 2022

ABSTRACT Rhabdomyosarcoma (RMS) is an aggressive, soft-tissue sarcoma in children. While many clinical trials have worked to improve patient outcomes, the 3-year survival rate for...

$427.5K
USD
Completed TRAINING, INDIVIDUAL
Development of Glypican-2 redirected T cells for the Treatment of Neuroblastoma
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital Gr... United States 2021 – 2022

Project Summary The objective of this proposal is to develop a T cell-based immunotherapy for the treatment of high-risk neuroblastoma (NB), for which outcomes remain poor. The ado...

$427.5K
USD
Completed NON-SBIR/STTR RPGS
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
NATIONAL CANCER INSTITUTE Yale University United States 2021 – 2023

PROJECT SUMMARY B cells critically depend on continuous survival and proliferation signals from a functional B cell receptor (BCR). Likewise, in ~50% of B cell malignancies, the tu...

$1.67M
USD
Completed NON-SBIR/STTR RPGS
A First-in-Class FAP-activated Protoxin to disrupt the Tumor-Stroma Parasitic Cycle fueling lethal Prostate Cancer Progression
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2025

Though initially responsive to hormonal therapy, prostate cancer (PCa) invariably progresses to an incurable metastatic castration-resistant state (mCRPC). Additionally, the propor...

$4.07M
USD